
    
      The current study is a Prospective, Multicenter, Randomized, Double-Blind, Phase 3 Study to
      Evaluate the Safety and Efficacy of a Gel Formulation of Esmolol Hydrochloride (Galnobax®) in
      Treating Diabetic Foot Ulcers. The study evaluates the safety and effectiveness of Galnobax®
      plus Standard of Care versus only Standard of Care, in treating Diabetic Foot Ulcers (DFU).
      In addition, Study is designed to investigate the safety of Galnobax® vehicle for
      establishing non-deleterious effects of Vehicle on wound healing in the Subjects with DFU.
    
  